GI Meling

1.9k total citations · 1 hit paper
19 papers, 1.4k citations indexed

About

GI Meling is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, GI Meling has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in GI Meling's work include Genetic factors in colorectal cancer (13 papers), Cancer Genomics and Diagnostics (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). GI Meling is often cited by papers focused on Genetic factors in colorectal cancer (13 papers), Cancer Genomics and Diagnostics (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). GI Meling collaborates with scholars based in Norway, India and China. GI Meling's co-authors include Ragnhild A. Lothe, TO Rognum, Minna Nyström, T I Andersen, Païvi Peltomäki, Ketil Heimdal, Lauri A. Aaltonen, L Pylkkänen, Pål Møller and TO Rognum and has published in prestigious journals such as Human Molecular Genetics, British Journal of Cancer and Cancer Letters.

In The Last Decade

GI Meling

19 papers receiving 1.4k citations

Hit Papers

Genomic instability in colorectal cancer: relationship to... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
GI Meling Norway 15 1.1k 909 476 366 157 19 1.4k
Olivier Buhard France 18 816 0.7× 611 0.7× 444 0.9× 406 1.1× 190 1.2× 28 1.2k
Constanze Pagenstecher Germany 22 1.4k 1.2× 908 1.0× 630 1.3× 469 1.3× 246 1.6× 27 1.7k
Nils Rahner Germany 17 658 0.6× 445 0.5× 331 0.7× 310 0.8× 126 0.8× 35 1.0k
Nasser Z. Parsa United States 15 764 0.7× 486 0.5× 158 0.3× 352 1.0× 46 0.3× 22 1.2k
Ravi Bansal United States 8 368 0.3× 750 0.8× 393 0.8× 553 1.5× 181 1.2× 9 1.1k
Laura Fontaine United States 10 296 0.3× 509 0.6× 284 0.6× 239 0.7× 85 0.5× 14 899
Erin Salo‐Mullen United States 15 355 0.3× 886 1.0× 588 1.2× 331 0.9× 177 1.1× 44 1.3k
T I Andersen Norway 4 668 0.6× 638 0.7× 365 0.8× 284 0.8× 97 0.6× 5 916
Maciej Giefing Poland 18 418 0.4× 396 0.4× 483 1.0× 631 1.7× 50 0.3× 56 1.2k
Kaori Tokino United States 6 307 0.3× 341 0.4× 251 0.5× 480 1.3× 282 1.8× 7 874

Countries citing papers authored by GI Meling

Since Specialization
Citations

This map shows the geographic impact of GI Meling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GI Meling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GI Meling more than expected).

Fields of papers citing papers by GI Meling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GI Meling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GI Meling. The network helps show where GI Meling may publish in the future.

Co-authorship network of co-authors of GI Meling

This figure shows the co-authorship network connecting the top 25 collaborators of GI Meling. A scholar is included among the top collaborators of GI Meling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GI Meling. GI Meling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Honne, Hilde, Stine A. Danielsen, Lina Cekaite, et al.. (2010). 694 Identification of novel epigenetic biomarkers in colorectal cancer, GLDC and PPP1R14A. European Journal of Cancer Supplements. 8(5). 175–175. 6 indexed citations
2.
Lind, Guro E., Stine A. Danielsen, Terje Ahlquist, et al.. (2009). 1321 A novel epigenetic biomarker panel for early detection of colorectal cancer and adenomas. European Journal of Cancer Supplements. 7(2). 145–145. 1 indexed citations
3.
4.
Løvig, T., GI Meling, Chieu B. Diep, et al.. (2002). APC and CTNNB1 Mutations in a Large Series of Sporadic Colorectal Carcinomas Stratified by the Microsatellite Instability Status. Scandinavian Journal of Gastroenterology. 37(10). 1184–1193. 30 indexed citations
5.
Løvig, T., Solveig Norheim Andersen, Lin Thorstensen, et al.. (2002). Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. British Journal of Cancer. 87(7). 756–762. 56 indexed citations
6.
Hoff-Olsen, P., GI Meling, & B. Olaisen. (1998). Variation in mutation rate and direction between tetranucleotide STR loci in human colorectal carcinomas. Annals of Human Genetics. 62(1). 1–7. 13 indexed citations
7.
Clausen, O. P. F., Ragnhild A. Lothe, Anne‐Lise Børresen‐Dale, et al.. (1998). Association of p53 Accumulation With TP53 Mutations, Loss of Heterozygosity at 17p13, and DNA Ploidy Status in 273 Colorectal Carcinomas. Diagnostic Molecular Pathology. 7(4). 215–223. 15 indexed citations
8.
Andersen, Solveig Norheim, T. Løvig, Jarle Breivik, et al.. (1997). K-rasMutations and Prognosis in Large-Bowel Carcinomas. Scandinavian Journal of Gastroenterology. 32(1). 62–69. 54 indexed citations
9.
Andersen, Solveig Norheim, Jarle Breivik, T. Løvig, et al.. (1996). K-ras mutations and HLA-DR expression in large bowel adenomas. British Journal of Cancer. 74(1). 99–108. 35 indexed citations
10.
Lothe, Ragnhild A., GI Meling, P. Morrison, et al.. (1995). Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Human Molecular Genetics. 4(11). 2065–2072. 141 indexed citations
11.
Breivik, Jarle, GI Meling, Anne Spurkland, TO Rognum, & Gustav Gaudernack. (1994). K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. British Journal of Cancer. 69(2). 367–371. 127 indexed citations
12.
Meling, GI, et al.. (1993). The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. British Journal of Cancer. 67(1). 93–98. 35 indexed citations
13.
Meling, GI, et al.. (1993). The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. British Journal of Cancer. 67(1). 88–92. 23 indexed citations
14.
Lothe, Ragnhild A., Païvi Peltomäki, GI Meling, et al.. (1993). Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.. PubMed. 53(24). 5849–52. 673 indexed citations breakdown →
15.
Rognum, TO, et al.. (1993). Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. British Journal of Cancer. 68(1). 80–85. 61 indexed citations
16.
Meling, GI, TO Rognum, O. P. F. Clausen, et al.. (1992). Serum Carcinoembryonic Antigen in Relation to Survival, DNA Ploidy Pattern, and Recurrent Disease in 406 Colorectal Carcinoma Patients. Scandinavian Journal of Gastroenterology. 27(12). 1061–1068. 19 indexed citations
17.
Kvale, Dag, Jarle Norstein, GI Meling, et al.. (1992). Circulating secretory component in relation to early diagnosis and treatment of liver metastasis from colorectal carcinomas.. Journal of Clinical Pathology. 45(7). 568–571. 5 indexed citations
18.
Meling, GI, et al.. (1991). Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. British Journal of Cancer. 64(3). 475–480. 54 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026